These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35132603)

  • 61. Modeling mechanisms underlying differential inflammatory responses to COVID-19 in type 2 diabetes using a patient-derived microphysiological organ-on-a-chip system.
    Negi V; Gavlock D; Miedel MT; Lee JK; Shun T; Gough A; Vernetti L; Stern AM; Taylor DL; Yechoor VK
    Lab Chip; 2023 Oct; 23(20):4514-4527. PubMed ID: 37766577
    [No Abstract]   [Full Text] [Related]  

  • 62. Pathogenesis and Management of COVID-19.
    Alfarouk KO; AlHoufie STS; Ahmed SBM; Shabana M; Ahmed A; Alqahtani SS; Alqahtani AS; Alqahtani AM; Ramadan AM; Ahmed ME; Ali HS; Bashir A; Devesa J; Cardone RA; Ibrahim ME; Schwartz L; Reshkin SJ
    J Xenobiot; 2021 May; 11(2):77-93. PubMed ID: 34063739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic.
    Debnath M; Berk M; Maes M
    Brain Behav Immun Health; 2020 May; 5():100096. PubMed ID: 32566934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm).
    Chhetri S; Khamis F; Pandak N; Al Khalili H; Said E; Petersen E
    IDCases; 2020; 21():e00829. PubMed ID: 32483525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
    Ghadiri F; Sahraian MA; Moghadasi AN
    Curr J Neurol; 2021 Oct; 20(4):248-249. PubMed ID: 38011439
    [No Abstract]   [Full Text] [Related]  

  • 66. Erratum to "Cytokine storm associated with severe COVID-19 infections: The potential mitigating role of omega-3 fatty acid triglycerides in the ICU".
    FASEB J; 2023 Aug; 37(8):e23119. PubMed ID: 37490044
    [No Abstract]   [Full Text] [Related]  

  • 67. Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears.
    Alruwaili M; Al-Kuraishy HM; Alexiou A; Papadakis M; ALRashdi BM; Elhussieny O; Saad HM; Batiha GE
    Neurochem Res; 2023 Nov; 48(11):3255-3269. PubMed ID: 37442896
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.
    Dutta S; Shah RB; Singhal S; Dutta SB; Bansal S; Sinha S; Haque M
    Drug Des Devel Ther; 2023; 17():1907-1932. PubMed ID: 37397787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation.
    Dwivedi DK; Jena GB
    J Biochem Mol Toxicol; 2023 Jul; 37(7):e23357. PubMed ID: 36999408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.
    Zahoor I; Li Y; Rattan R; Giri S
    Adv Exp Med Biol; 2021; 1352():211-222. PubMed ID: 35132603
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 and cancer: start the resolution!
    Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
    Beigel JH; Tomashek KM; Dodd LE
    N Engl J Med; 2020 Sep; 383(10):994. PubMed ID: 32649078
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.